FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/070061 [Registered on: 05/07/2024] Trial Registered Prospectively
Last Modified On: 02/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Analgesic Efficacy Of Transdermal Buprenorphine For Postoperative Pain In Patients Undergoing Lumbar Discectomy 
Scientific Title of Study   Comparison Of Analgesic Efficacy Of Transdermal Buprenorphine For Postoperative Pain With Control Group In Patients Undergoing Lumbar Discectomy 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Lekha Shree R 
Designation  Junior Resident  
Affiliation  Sapthagiri Institute Of Medical Sciences And Research Centre 
Address  Department Of Anaesthesia Sapthagiri Institute Of Medical Sciences And Research Centre, No. 15, Chikkasandra, Hesaraghatta Main Road, Bengaluru -560090 Karnataka India

Bangalore
KARNATAKA
560090
India 
Phone  8197358214  
Fax    
Email  lekhashree96@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Manjunath A C 
Designation  Professor  
Affiliation  Sapthagiri Institute Of Medical Sciences And Research Centre 
Address  Department Of Anaesthesia Sapthagiri Institute Of Medical Sciences And Research Centre, No. 15, Chikkasandra, Hesaraghatta Main Road, Bengaluru -560090 Karnataka India

Bangalore
KARNATAKA
560090
India 
Phone  8123540084  
Fax    
Email  manjumac5@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Manjunath A C 
Designation  Professor 
Affiliation  Sapthagiri Institute Of Medical Sciences And Research Centre 
Address  Department Of Anaesthesia Sapthagiri Institute Of Medical Sciences And Research Centre, No. 15, Chikkasandra, Hesaraghatta Main Road, Bengaluru -560090 Karnataka India

Bangalore
KARNATAKA
560090
India 
Phone  8123540084  
Fax    
Email  manjumac5@gmail.com  
 
Source of Monetary or Material Support  
Sapthagiri Institute Of Medical Sciences And Research Centre No. 15, Chikkasandra, Hesaraghatta Main Road, Bengaluru -560090 Karnataka India 
 
Primary Sponsor  
Name  Sapthagiri Institute Of Medical Sciences And Research Centre 
Address  No. 15, Chikkasandra, Hesaraghatta Main Road, Bengaluru -560090 Karnataka India  
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Lekha Shree R  Sapthagiri Institute Of Medical Sciences And Research Centre   Department Of Anaesthesia OT complex 4th floor No. 15, Chikkasandra, Hesaraghatta Main Road, Bengaluru -560090 Karnataka, INDIA
Bangalore
KARNATAKA 
8197358214

lekhashree96@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SAPTHAGIRI INSTITUTE OF MEDICAL SCIENCES AND RESEARCH CENTRE   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M511||Thoracic, thoracolumbar and lumbosacral intervertebral disc disorders with radiculopathy,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Buprenorphine   Route- Transdermal Dose- 10mcg/hr Frequency- Applied night before surgery  
Comparator Agent  Inj Paracetamol  Inj Paracetamol 1g IV is used as a control given intraoperatively . 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  ASA grade I and II
Age 18-60yrs
Posted for lumbar discectomy
 
 
ExclusionCriteria 
Details  Patients not willing to participate in the study
Patients on any other form of opioid therapy for chronic pain
History of drug allergy or application
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To compare postoperative VAS score in patients receiving buprenorphine patch v/s control who wont receive buprenorphine patch  VAS score , HR , BP , SPO2 will be assessed at 0, 2, 4, 8, 12, 24 and 48hrs in both the groups and recorded 
 
Secondary Outcome  
Outcome  TimePoints 
Time to first rescue analgesic.
Total rescue analgesic.
 
Time of first rescue analgesia, total analgesic consumption will be recorded in first 48 hours. 
 
Target Sample Size   Total Sample Size="42"
Sample Size from India="42" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   15/07/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Transdermal patches for NSAIDS and opioids offer the advantage of sustained drug delivery, bioavailability, and avoidance of first-pass metabolism which reduces systemic effects. They have a one-time application, reduce workload on health-care workers, and prevent waxing-waning of analgesia due to diminishing blood levels.It has been widely applied in treating chronic low back pain displaying excellent results.This study is undertaken to see the effect of transdermal buprenorphine on postoperative pain after lumbar discectomy.


Patients posted for lumbar discectomy in Sapthagiri Institute of Medical Sciences  who fulfil the inclusion criteria will be enrolled for the study. Patients will be randomised into 2 equal groups of 42 each  [Group B and Group C] using computer generated table of random numbers.

Group B: Receiving transdermal buprenorphine patch 10 mg the night before surgery

Group C : Control group who will not receive buprenorphine patch

Group B patients will receive transdermal Buprenorphine 10mcg/hr patch night before surgery. Analgesia IV Paracetamol 1g  will be given after intubation in both groups. Intraoperative hemodynamic parameters like HR , BP , SPO2  will be noted at baseline, induction, 5 mins and 10 mins. VAS score , HR , BP , SPO2 will be assessed at 0, 2, 4, 8, 12, 24 and 48hrs in both the groups and recorded. Inj Tramadol 2 mg/kg (maximum 100mg) IV will be administered when VAS>3 as rescue analgesic.VAS score, time of first rescue analgesia, total analgesic consumption will be recorded in  first 48 hours and compared between both groups.



 

 
Close